1. bookVolume 21 (2013): Issue 4 (December 2013)
Journal Details
License
Format
Journal
eISSN
2284-5623
ISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Open Access

Spread of VIM-2 metallo-beta-lactamase in Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from Iaşi, Romania

Journal Details
License
Format
Journal
eISSN
2284-5623
ISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English

1. Gupta V. Metallo beta lactamases in Pseudomonasaeruginosa and Acinetobacter species. Expert Opin Investig Drugs. 2008 Feb; 17(2):131-43.10.1517/13543784.17.2.131Search in Google Scholar

2. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo- β-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005 Apr; 18:306-325.10.1128/CMR.18.2.306-325.2005Search in Google Scholar

3. Walsh F, Amyes SG. Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. J Chemother. 2007 Aug; 19:376-381.10.1179/joc.2007.19.4.376Search in Google Scholar

4. Cornaglia G, Giamarellou H, Rossolini GM. Metallo- β-lactamases: a last frontier for β-lactams? Lancet Infect Dis. 2011 May; 11(5):381-393.10.1016/S1473-3099(11)70056-1Search in Google Scholar

5. Giakkoupi P, Petrikkos G, Tzouvelekis L, Tsonas S, Legakis N, Vatopoulos A. Spread of integron-associated VIM-type metallo-β-lactamase genes among imipenemnonsusceptible Pseudomonas aeruginosa strains in Greek hospitals. J Clin Microbiol. 2003 Feb; 41(2): 822-825.10.1128/JCM.41.2.822-825.200314967512574292Search in Google Scholar

6. Rossolini GM, Luzzaro F, Migliavacca R, Mugnaioli C, Pini B, De Luca F, et al. First countrywide survey of acquired metallo-β-lactamases in gram-negative pathogens in Italy. Antimicrob Agents Chemother. 2008 Nov; 52(11):4023-4029.10.1128/AAC.00707-08257311318809945Search in Google Scholar

7. Hocquet D, Plésiat P, Dehecq B, Mariotte P, Talon D, Bertrand X. Nationwide investigation of extended-spectrum β-lactamases, metallo-β-lactamases, and extended- spectrum oxacillinases produced by ceftazidime- resistant Pseudomonas aeruginosa strains in France. Antimicrob Agents Chemother. 2010 Aug; 54(8):3512-3515.10.1128/AAC.01646-09291634720547814Search in Google Scholar

8. Valenza G, Joseph B, Elias J, Heike C, Oesterlein A, Engelhardt K, et al. First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital. Antimicrob Agents Chemother. 2010 Aug; 54(8): 3493-3497.10.1128/AAC.00080-10291632120498315Search in Google Scholar

9. www.lahey.org/StudiesSearch in Google Scholar

10. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, et al. Characterization of VIM-2, a carbapenem- hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000 Apr; 44(4):891-897.10.1128/AAC.44.4.891-897.20008978810722487Search in Google Scholar

11. Zhao WH, Hu ZQ. Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli. Future Microbiol. 2011 Mar; 6(3):317-333.10.2217/fmb.11.1321449842Search in Google Scholar

12. Elias J, Schoen C, Heinze G, Valenza G, Gerharz E, Riedmiller H, et al. Nosocomial outbreak of VIM-2 metallo- β-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography. Clin Microbiol Infect. 2010 Sept; 16(9):1494-1500.10.1111/j.1469-0691.2010.03146.xSearch in Google Scholar

13. Van der Bij A, Van Mansfeld R, Peirano G, Goessens W, Severin J, Pitout J, et al. First outbreak of VIM-2 metallo- β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes. Int J Antimicrob Agents. 2011 Jun; 37(6):513-518.10.1016/j.ijantimicag.2011.02.010Search in Google Scholar

14. Viedma E, Juan C, Villa J, Barrado L, Orellana MA, Sanz F, et al. VIM-2-producing multidrug-resistant Pseudomonasaeruginosa ST175 clone, Spain. Emerg Infect Dis. 2012 Aug; 18(8): 1235-1241.10.3201/eid1808.111234Search in Google Scholar

15. Cernat R, Balotescu C, Lazar V, Banu O, Ivanescu D, Bucur M. Genetic characterisation of highly prevalent MBLs and OXA carbapenemases in multidrug-resistant Acinetobacter baumannii strains in a Romanian hospital. Clin Microbiol Infect. 2007 Apr; 13(s1):O436.10.1016/S0924-8579(07)70290-XSearch in Google Scholar

16. Mereuta AI, Docquier JD, Rossolini GM, Buiuc D. Detection of metallo-beta-lactamases in gram-negative bacilli isolated in hospitals from Romania-research fellowship report. Bacteriol Virusol Parazitol Epidemiol. 2007 Jan-Jun; 52:45-49.Search in Google Scholar

17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 22th informational supplement. 2012. CLSI M100-S22, Wayne, PA.Search in Google Scholar

18. Migliavacca R, Docquier JD, Mugnaioli C, Amicosante G, Daturi R, Lee KW, et al. Simple microdilution test for detection of metallo-β-lactamase production in Pseudomonas aeruginosa. J Clin Microbiol. 2002 Nov; 40(11):4388-4390.10.1128/JCM.40.11.4388-4390.200213963812409438Search in Google Scholar

19. Docquier JD, Riccio ML, Mugnaioli C, Luzzaro F, Endimiani A, Toniolo A, et al. IMP-12, a new plasmid encoded metallo-β-lactamase from a Pseudomonas putida clinical isolate. Antimicrob Agents Chemother. 2003 May; 47(5):1522-1528.10.1128/AAC.47.5.1522-1528.200315331912709317Search in Google Scholar

20. Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR. How to detect NDM-1 producers. J Clin Microbiol. 2011 Feb; 49(2): 718-721.10.1128/JCM.01773-10304350721123531Search in Google Scholar

21. Campbell M, Mahenthiralingam E, Speert DP. Evaluation of Random Amplified Polymorphic DNA Typing of Pseudomonas aeruginosa. J Clin Microbiol. 2000 Dec; 38 (12):4614-4615.10.1128/JCM.38.12.4614-4615.20008764511101604Search in Google Scholar

22. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug- resistant and pandrug-resistant: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar; 18(3): 268-281.10.1111/j.1469-0691.2011.03570.x21793988Search in Google Scholar

23. Zhao WH, Chen G, Ito R, Hu ZQ. Relevance of resistance levels to carbapenems and integron-borne blaIMP-1, blaIMP-7, blaIMP-10 and blaVIM-2 in clinical isolates of Pseudomonasaeruginosa. J Med Microbiol. 2009 Aug; 58(8):1080-1085.10.1099/jmm.0.010017-019528141Search in Google Scholar

24. Franco MRG, Caiaffa-Filho HH, Burattini MN, Rossi F. Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics. 2010; 65(9):825-829.10.1590/S1807-59322010000900002295473121049207Search in Google Scholar

25. Jovcic B, Vasiljevcic Z, Djukic S, Topisirovic L, Kojic M. Emergence of VIM-2 metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in a paediatric hospital in Serbia. J Med Microbiol. 2011 Jun; 60(6): 868-869.10.1099/jmm.0.029173-021330409Search in Google Scholar

26. Ratkai C, Quinteira S, Grosso F, Monteiro N, Nagy E, Peixe L. Controlling for false positives: interpreting MBL Etest and MBL combined disc test for the detection of metallo-β-lactamases. J Antimicrob Chemother. 2009 Sept; 64(3):657-658.10.1093/jac/dkp22919567407Search in Google Scholar

27. Samuelsen O, Buarø L, Giske CG, Simonsen GS, Aasnaes B, Sundsfjord A. Evaluation of phenotypic tests for the detection of metallo-β-lactamase-producing Pseudomonasaeruginosa in a low prevalence country. J Antimicrob Chemother. 2008 Apr; 61(4):827-830.10.1093/jac/dkn01618227087Search in Google Scholar

28. Khosravi Y, Tay ST, Vadivelu J. Analysis of integrons and associated gene cassettes of metallo-β-lactamase- positive Pseudomonas aeruginosa in Malaysia. J Med Microbiol. 2011 Jul; 60 (7):988-994.10.1099/jmm.0.029868-021436370Search in Google Scholar

29. Hammami S, Gautier V, Ghozzi R, Da Costa A, Ben- Redjeb S, Arlet G. Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin Microbiol Infect. 2010 Feb; 16(2):189-193.10.1111/j.1469-0691.2009.03023.x19686278Search in Google Scholar

30. Straut M, Dinu S, Cretoiu S, Lixandru B, Surdeanu M. Molecular characterization of genetic structures surrounding blaVIM-2 gene identified in Pseudomonas aeruginosa clinical isolates from Romania. Clin Microbiol Infect. 2010 Apr; 16(S2):197.Search in Google Scholar

31. Toleman MA, Vinodh H, Sekar U, Kamat V, Walsh TR. blaVIM-2 - harbouring integrons isolated in India, Russia and United States arise from an ancestral class 1 integron predating the formation of 3' conserved sequence. Antimicrob Agents Chemother. 2007 Jul; 51(7): 2336-2638. 10.1128/AAC.01043-06191326817438051Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo